Сomorbidities, risk factors and causes of death in patients with myocardial infarction of different prescription, based on follow-up after hospitalization at a multidisciplinary center
Authors:
- M. M. Luk'YAnovMLM. M. Luk'YAnov
- R. N. ShepelRSR. N. Shepel
- E. Yu. OkshinaEOE. Yu. Okshina
- E. Yu. AndreenkoEAE. Yu. Andreenko
- A. A. SmirnovASA. A. Smirnov
- N. N. KuzinaNKN. N. Kuzina
- A. G. SoplenkovaASA. G. Soplenkova
- E. V. StepanovaESE. V. Stepanova
- M. N. ValiakhmetovMVM. N. Valiakhmetov
- A. A. SavishchevaASA. A. Savishcheva
- O. M. DrapkinaODO. M. Drapkina
Open Access
- 8 February 2026
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4690
Abstract
Aim. To analyze multimorbidity, risk factors for death, its incidence, and causes, based on long-term follow-up after hospitalization at a multidisciplinary center for acute myocardial infarction (MI) or other pathologies associated with old myocardial infarction. Material and methods. The SOFIT registry included 855 patients treated for acute MI and 1341 patients treated for other pathologies associated with old MI (age (M±SD) — 64,1±12,1 and 65,8±10,9 years; men — 65,6% and 69,7%). The median [interquartile range] follow-up duration was 2,6 [2,2; 2,9] years. Results. Multimorbidity in the comparison groups was recorded in 97,1 and 94,8% of cases (p=0,01), while cardiovascular multimorbidity — in 95,4 and 86,1% (pConclusion. Patients after myocardial infarction (MI), regardless of its duration, are characterized by a high death risk due to comorbid pathology, which is significantly reduced by appropriate combination cardiovascular pharmacotherapy.Keywords
This publication has 27 references indexed in Scilit:
- Three-year outcomes of post-acute sequelae of COVID-19Nature Medicine, 2024
- 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort studyThe Lancet Respiratory Medicine, 2023
- Temporal Trends in Noncardiovascular Morbidity and Mortality Following Acute Myocardial InfarctionJACC, 2023
- 2023 ESC Guidelines for the management of acute coronary syndromesEuropean Heart Journal, 2023
- Recurrent myocardial infarction and emergency department visits: a retrospective study on the Stockholm Area Chest Pain CohortOpen Heart, 2023
- Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United StatesJAMA Network Open, 2019
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspectiveEuropean Heart Journal, 2015
- Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patientsEuropean Heart Journal, 2013
- Long-Term Survival and Recurrence After Acute Myocardial Infarction in England, 2004 to 2010Circulation: Cardiovascular Quality and Outcomes, 2012
- Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide studyDiabetologia, 2010